The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of lanreotide depot (LAN) for symptomatic control of carcinoid syndrome (CS) in patients with neuroendocrine tumor (NET) previously responsive to octreotide (OCT): Subanalysis of patient-reported symptoms from the phase III ELECT study.
 
Rodney F. Pommier
Honoraria - Ipsen
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Celgene; ipsen
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); EpicentRx (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); Sun Pharma (Inst); Tercica (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Advanced Accelerator Applications; Esanex; Genentech/Roche; Lexicon; Merck; Novartis; Oxigene
 
Nilani Liyanage
Employment - Ipsen
 
Susan W. Pitman Lowenthal
Employment - Ipsen
 
Beloo Mirakhur
Employment - Ipsen
 
Montaser F. Shaheen
No Relationships to Disclose
 
Aaron Vinik
Consulting or Advisory Role - Isis Pharmaceuticals; Merck; Neurometrix; Pamlab; Pfizer
Speakers' Bureau - Merck; Pamlab
Research Funding - Daiichi Sankyo; Impeto Medical; Intarcia Therapeutics; Pfizer; Tercica; ViroMed